1 May 2026Oral drugsSource update: September 2022
Cefixime oral
Cefixime guidance for typhoid fever, selected urinary infections, gonorrhea, and second-line shigellosis treatment.
Prescription under medical supervision
This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.
Therapeutic action
Third-generation cephalosporin antibacterial.
Indications
- Typhoid fever.
- Acute cystitis in girls over 2 years, pregnant women, and lactating women.
- Acute pyelonephritis in adults.
- Cervicitis and urethritis due to Neisseria gonorrhoeae in combination with a treatment for chlamydia.
- Second-line treatment of shigellosis.
Forms and strengths
- 200 mg tablet.
- 100 mg/5 ml powder for oral suspension, to be reconstituted with filtered water.
Dose
Typhoid fever
- Child: 10 mg/kg, maximum 200 mg, 2 times daily.
- Adult: 200 mg 2 times daily.
Acute cystitis in girls over 2 years and shigellosis
- Child: 8 mg/kg, maximum 400 mg, once daily.
- Adult: 400 mg once daily.
Acute cystitis in pregnant and lactating women, acute pyelonephritis in adult
- Adult: 200 mg 2 times daily.
Cervicitis and urethritis due to Neisseria gonorrhoeae
- Child: 8 mg/kg, maximum 400 mg, single dose.
- Adult: 400 mg single dose.
Duration
- Typhoid fever and acute pyelonephritis: 10 to 14 days.
- Acute cystitis: 3 days for girls and 5 days for adults.
- Shigellosis: 5 days.
Contra-indications, adverse effects, precautions
- Do not administer to patients with allergy to cephalosporins.
- Administer with caution to penicillin-allergic patients because cross-sensitivity may occur, and in patients with severe renal impairment by reducing dosage.
- May cause gastrointestinal disturbances, especially diarrhoea, headache, dizziness, and allergic reactions such as rash, pruritus, and fever.
- In the event of allergic reaction, stop treatment immediately.
- Pregnancy: no contra-indication.
- Breast-feeding: no contra-indication.
Source
MSF Essential drugs practical guidelines (January 2026)
This page reproduces the structured reference information for this batch while leaving out the Storage and Remarks sections.
Rate this guide
Be the first to rate this guide.
